Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium hydroxide versus silver nanoparticle intracanal medicament trial
PACTR201602001444180Recruiting
- Sponsor
- Fatma El-Zahraa Osman El-Abbasy
- Start
- Feb 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of calcium hydroxide and silver nanoparticles in pulpitis (2 arms), sponsored by Fatma El-Zahraa Osman El-Abbasy. Primary endpoint: post-operative pain. Started Feb 2016; status: recruiting.
02
Drugs
calcium hydroxidesilver nanoparticles
03
Conditions
pulpitis
Beyond the preview
Go deeper on PACTR201602001444180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201602001444180.